Search

everythinglearnresearchcommunity

for

Search:↓

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

The free androgen index varies among women with different types of PCOS.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

Vitamin D may help improve hormone levels in women with PCOS.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Perforin and granzyme-B may influence hormone levels in women with PCOS.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

FAI is a better marker for predicting female hair loss than testosterone or SHBG alone.

The Free Androgen Index is important for diagnosing PCOS due to its strong link with symptoms and risk factors.

Early-onset hair loss in Egyptian males is linked to genetics, hormones, and lifestyle factors like smoking and diet.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Neurokinin B levels are higher in the placentas of women with PCOS who have female babies.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.

Hormonal imbalances are important in the development of male pattern baldness.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Laparoscopic ovarian drilling improves menstrual cycles, hormone levels, and pregnancy rates in women with PCOS.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

MC1R gene variations affect skin, hair color, UV sensitivity, and melanoma risk.

Risk analysis is important for safely adjusting pharmaceutical formulas while maintaining their quality and effectiveness.

Herbal remedies can cause adverse effects and need more safety research.